title: Could zinc oxide tetrapod nanoparticles be used as an effective immunotherapy against HSV-2?
authors.affiliation: Department of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
authors.forename: Tejabhiram
authors.initials: T
authors.lastname: Yadavalli
authors.affiliation: Department of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.|Department of Microbiology & Immunology, College of Medicine, University of Illinois at Chicago, 1855 West Taylor Street, Chicago, IL 60612, USA.
authors.forename: Deepak
authors.initials: D
authors.lastname: Shukla
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002460:Cell Line; D006558:Herpes Genitalis / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D018258:Herpesvirus 2, Human / Q000187:drug effects* / Q000276:immunology; D022283:Herpesvirus Vaccines / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D053768:Metal Nanoparticles / Q000737:chemistry*; D013499:Surface Properties; D014611:Vaccination / Q000379:methods; D015034:Zinc Oxide / Q000737:chemistry*
chemical_list: D000998:Antiviral Agents; D022283:Herpesvirus Vaccines; D015034:Zinc Oxide
keywords: herpes simplex virus; immunotherapy; microbivac; virus entry; zinc oxide nanoparticles